Dr Tellier joins MacroGenics after a 20 year career in commercial development at Novartis. Since February 2007, he served as chairman and CEO of Novartis Pharma France and Novartis Group France.
Mr James Karrels brings a wealth of financial and analytical experience to MacroGenics. He has been at Jazz Pharmaceuticals, since 2005, most recently serving as executive director of Finance. While at Jazz Pharmaceuticals, he was responsible for the company’s financial planning and analysis and investor relations activities.
Scott Koenig, president and CEO of MacroGenics, said: “Both Jean-Christophe and Jim exhibit personal qualities and experiences that are among the best in the biotechnology and pharmaceutical industry, and they will complement the skills of our already extraordinary management group, as we position our company for growth and advance our pipeline towards commercialization.”